Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Saliva-based Screening Market Growth (Status and Outlook) 2022-2028

  • LP 4970847
  • 124 Pages
  • July 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Saliva-based Screening will have significant change from previous year. According to our (LP Information) latest study, the global Saliva-based Screening market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Saliva-based Screening market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Saliva-based Screening market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Saliva-based Screening market, reaching US$ million by the year 2028. As for the Europe Saliva-based Screening landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Saliva-based Screening players cover Thermo Fisher scientific, Qiagen, Hologic, and Takara Bio Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Saliva-based Screening market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Direct Sample to PCR

RT-qPCR

Lateral Flow Assays

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Diagnostic Laboratories

Hospitals & Clinics

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Thermo Fisher scientific

Qiagen

Hologic

Takara Bio Inc

Arcis Biotechnology Limited

GeneProof

Abacus ALS

Chai Inc.

Kolplast Group

Lucence Health INc

Vitagene

Therma Bright Inc

ACON Laboratories, Inc

TODA PHARMA

Norgen Biotek Corp.

Assure Tech. (Hangzhou) Co., Ltd

Beijing Hotgen Biotech Co., Ltd

Nantong Diagnos Biotechnology Co., Ltd

NeuMoDx Molecular, Inc.

KYODO INTERNATIONAL INC.

Canvax

Zymo Research Corporation.

Salimetrics

NEST Scientific USA

Miraclean Technology Co. Ltd

Mawi DNA Technologies

Cell Projects Ltd.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Saliva-based Screening Market Size 2017-2028

2.1.2 Saliva-based Screening Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Saliva-based Screening Segment by Type

2.2.1 Direct Sample to PCR

2.2.2 RT-qPCR

2.2.3 Lateral Flow Assays

2.3 Saliva-based Screening Market Size by Type

2.3.1 Saliva-based Screening Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Saliva-based Screening Market Size Market Share by Type (2017-2022)

2.4 Saliva-based Screening Segment by Application

2.4.1 Diagnostic Laboratories

2.4.2 Hospitals & Clinics

2.4.3 Others

2.5 Saliva-based Screening Market Size by Application

2.5.1 Saliva-based Screening Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Saliva-based Screening Market Size Market Share by Application (2017-2022)

3 Saliva-based Screening Market Size by Player

3.1 Saliva-based Screening Market Size Market Share by Players

3.1.1 Global Saliva-based Screening Revenue by Players (2020-2022)

3.1.2 Global Saliva-based Screening Revenue Market Share by Players (2020-2022)

3.2 Global Saliva-based Screening Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Saliva-based Screening by Regions

4.1 Saliva-based Screening Market Size by Regions (2017-2022)

4.2 Americas Saliva-based Screening Market Size Growth (2017-2022)

4.3 APAC Saliva-based Screening Market Size Growth (2017-2022)

4.4 Europe Saliva-based Screening Market Size Growth (2017-2022)

4.5 Middle East & Africa Saliva-based Screening Market Size Growth (2017-2022)

5 Americas

5.1 Americas Saliva-based Screening Market Size by Country (2017-2022)

5.2 Americas Saliva-based Screening Market Size by Type (2017-2022)

5.3 Americas Saliva-based Screening Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Saliva-based Screening Market Size by Region (2017-2022)

6.2 APAC Saliva-based Screening Market Size by Type (2017-2022)

6.3 APAC Saliva-based Screening Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Saliva-based Screening by Country (2017-2022)

7.2 Europe Saliva-based Screening Market Size by Type (2017-2022)

7.3 Europe Saliva-based Screening Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Saliva-based Screening by Region (2017-2022)

8.2 Middle East & Africa Saliva-based Screening Market Size by Type (2017-2022)

8.3 Middle East & Africa Saliva-based Screening Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Saliva-based Screening Market Forecast

10.1 Global Saliva-based Screening Forecast by Regions (2023-2028)

10.1.1 Global Saliva-based Screening Forecast by Regions (2023-2028)

10.1.2 Americas Saliva-based Screening Forecast

10.1.3 APAC Saliva-based Screening Forecast

10.1.4 Europe Saliva-based Screening Forecast

10.1.5 Middle East & Africa Saliva-based Screening Forecast

10.2 Americas Saliva-based Screening Forecast by Country (2023-2028)

10.2.1 United States Saliva-based Screening Market Forecast

10.2.2 Canada Saliva-based Screening Market Forecast

10.2.3 Mexico Saliva-based Screening Market Forecast

10.2.4 Brazil Saliva-based Screening Market Forecast

10.3 APAC Saliva-based Screening Forecast by Region (2023-2028)

10.3.1 China Saliva-based Screening Market Forecast

10.3.2 Japan Saliva-based Screening Market Forecast

10.3.3 Korea Saliva-based Screening Market Forecast

10.3.4 Southeast Asia Saliva-based Screening Market Forecast

10.3.5 India Saliva-based Screening Market Forecast

10.3.6 Australia Saliva-based Screening Market Forecast

10.4 Europe Saliva-based Screening Forecast by Country (2023-2028)

10.4.1 Germany Saliva-based Screening Market Forecast

10.4.2 France Saliva-based Screening Market Forecast

10.4.3 UK Saliva-based Screening Market Forecast

10.4.4 Italy Saliva-based Screening Market Forecast

10.4.5 Russia Saliva-based Screening Market Forecast

10.5 Middle East & Africa Saliva-based Screening Forecast by Region (2023-2028)

10.5.1 Egypt Saliva-based Screening Market Forecast

10.5.2 South Africa Saliva-based Screening Market Forecast

10.5.3 Israel Saliva-based Screening Market Forecast

10.5.4 Turkey Saliva-based Screening Market Forecast

10.5.5 GCC Countries Saliva-based Screening Market Forecast

10.6 Global Saliva-based Screening Forecast by Type (2023-2028)

10.7 Global Saliva-based Screening Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Thermo Fisher scientific

11.1.1 Thermo Fisher scientific Company Information

11.1.2 Thermo Fisher scientific Saliva-based Screening Product Offered

11.1.3 Thermo Fisher scientific Saliva-based Screening Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Thermo Fisher scientific Main Business Overview

11.1.5 Thermo Fisher scientific Latest Developments

11.2 Qiagen

11.2.1 Qiagen Company Information

11.2.2 Qiagen Saliva-based Screening Product Offered

11.2.3 Qiagen Saliva-based Screening Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Qiagen Main Business Overview

11.2.5 Qiagen Latest Developments

11.3 Hologic

11.3.1 Hologic Company Information

11.3.2 Hologic Saliva-based Screening Product Offered

11.3.3 Hologic Saliva-based Screening Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Hologic Main Business Overview

11.3.5 Hologic Latest Developments

11.4 Takara Bio Inc

11.4.1 Takara Bio Inc Company Information

11.4.2 Takara Bio Inc Saliva-based Screening Product Offered

11.4.3 Takara Bio Inc Saliva-based Screening Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Takara Bio Inc Main Business Overview

11.4.5 Takara Bio Inc Latest Developments

11.5 Arcis Biotechnology Limited

11.5.1 Arcis Biotechnology Limited Company Information

11.5.2 Arcis Biotechnology Limited Saliva-based Screening Product Offered

11.5.3 Arcis Biotechnology Limited Saliva-based Screening Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Arcis Biotechnology Limited Main Business Overview

11.5.5 Arcis Biotechnology Limited Latest Developments

11.6 GeneProof

11.6.1 GeneProof Company Information

11.6.2 GeneProof Saliva-based Screening Product Offered

11.6.3 GeneProof Saliva-based Screening Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 GeneProof Main Business Overview

11.6.5 GeneProof Latest Developments

11.7 Abacus ALS

11.7.1 Abacus ALS Company Information

11.7.2 Abacus ALS Saliva-based Screening Product Offered

11.7.3 Abacus ALS Saliva-based Screening Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Abacus ALS Main Business Overview

11.7.5 Abacus ALS Latest Developments

11.8 Chai Inc.

11.8.1 Chai Inc. Company Information

11.8.2 Chai Inc. Saliva-based Screening Product Offered

11.8.3 Chai Inc. Saliva-based Screening Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Chai Inc. Main Business Overview

11.8.5 Chai Inc. Latest Developments

11.9 Kolplast Group

11.9.1 Kolplast Group Company Information

11.9.2 Kolplast Group Saliva-based Screening Product Offered

11.9.3 Kolplast Group Saliva-based Screening Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Kolplast Group Main Business Overview

11.9.5 Kolplast Group Latest Developments

11.10 Lucence Health INc

11.10.1 Lucence Health INc Company Information

11.10.2 Lucence Health INc Saliva-based Screening Product Offered

11.10.3 Lucence Health INc Saliva-based Screening Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Lucence Health INc Main Business Overview

11.10.5 Lucence Health INc Latest Developments

11.11 Vitagene

11.11.1 Vitagene Company Information

11.11.2 Vitagene Saliva-based Screening Product Offered

11.11.3 Vitagene Saliva-based Screening Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Vitagene Main Business Overview

11.11.5 Vitagene Latest Developments

11.12 Therma Bright Inc

11.12.1 Therma Bright Inc Company Information

11.12.2 Therma Bright Inc Saliva-based Screening Product Offered

11.12.3 Therma Bright Inc Saliva-based Screening Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Therma Bright Inc Main Business Overview

11.12.5 Therma Bright Inc Latest Developments

11.13 ACON Laboratories, Inc

11.13.1 ACON Laboratories, Inc Company Information

11.13.2 ACON Laboratories, Inc Saliva-based Screening Product Offered

11.13.3 ACON Laboratories, Inc Saliva-based Screening Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 ACON Laboratories, Inc Main Business Overview

11.13.5 ACON Laboratories, Inc Latest Developments

11.14 TODA PHARMA

11.14.1 TODA PHARMA Company Information

11.14.2 TODA PHARMA Saliva-based Screening Product Offered

11.14.3 TODA PHARMA Saliva-based Screening Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 TODA PHARMA Main Business Overview

11.14.5 TODA PHARMA Latest Developments

11.15 Norgen Biotek Corp.

11.15.1 Norgen Biotek Corp. Company Information

11.15.2 Norgen Biotek Corp. Saliva-based Screening Product Offered

11.15.3 Norgen Biotek Corp. Saliva-based Screening Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Norgen Biotek Corp. Main Business Overview

11.15.5 Norgen Biotek Corp. Latest Developments

11.16 Assure Tech. (Hangzhou) Co., Ltd

11.16.1 Assure Tech. (Hangzhou) Co., Ltd Company Information

11.16.2 Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Product Offered

11.16.3 Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Assure Tech. (Hangzhou) Co., Ltd Main Business Overview

11.16.5 Assure Tech. (Hangzhou) Co., Ltd Latest Developments

11.17 Beijing Hotgen Biotech Co., Ltd

11.17.1 Beijing Hotgen Biotech Co., Ltd Company Information

11.17.2 Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Product Offered

11.17.3 Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Beijing Hotgen Biotech Co., Ltd Main Business Overview

11.17.5 Beijing Hotgen Biotech Co., Ltd Latest Developments

11.18 Nantong Diagnos Biotechnology Co., Ltd

11.18.1 Nantong Diagnos Biotechnology Co., Ltd Company Information

11.18.2 Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Product Offered

11.18.3 Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 Nantong Diagnos Biotechnology Co., Ltd Main Business Overview

11.18.5 Nantong Diagnos Biotechnology Co., Ltd Latest Developments

11.19 NeuMoDx Molecular, Inc.

11.19.1 NeuMoDx Molecular, Inc. Company Information

11.19.2 NeuMoDx Molecular, Inc. Saliva-based Screening Product Offered

11.19.3 NeuMoDx Molecular, Inc. Saliva-based Screening Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 NeuMoDx Molecular, Inc. Main Business Overview

11.19.5 NeuMoDx Molecular, Inc. Latest Developments

11.20 KYODO INTERNATIONAL INC.

11.20.1 KYODO INTERNATIONAL INC. Company Information

11.20.2 KYODO INTERNATIONAL INC. Saliva-based Screening Product Offered

11.20.3 KYODO INTERNATIONAL INC. Saliva-based Screening Revenue, Gross Margin and Market Share (2020-2022)

11.20.4 KYODO INTERNATIONAL INC. Main Business Overview

11.20.5 KYODO INTERNATIONAL INC. Latest Developments

11.21 Canvax

11.21.1 Canvax Company Information

11.21.2 Canvax Saliva-based Screening Product Offered

11.21.3 Canvax Saliva-based Screening Revenue, Gross Margin and Market Share (2020-2022)

11.21.4 Canvax Main Business Overview

11.21.5 Canvax Latest Developments

11.22 Zymo Research Corporation.

11.22.1 Zymo Research Corporation. Company Information

11.22.2 Zymo Research Corporation. Saliva-based Screening Product Offered

11.22.3 Zymo Research Corporation. Saliva-based Screening Revenue, Gross Margin and Market Share (2020-2022)

11.22.4 Zymo Research Corporation. Main Business Overview

11.22.5 Zymo Research Corporation. Latest Developments

11.23 Salimetrics

11.23.1 Salimetrics Company Information

11.23.2 Salimetrics Saliva-based Screening Product Offered

11.23.3 Salimetrics Saliva-based Screening Revenue, Gross Margin and Market Share (2020-2022)

11.23.4 Salimetrics Main Business Overview

11.23.5 Salimetrics Latest Developments

11.24 NEST Scientific USA

11.24.1 NEST Scientific USA Company Information

11.24.2 NEST Scientific USA Saliva-based Screening Product Offered

11.24.3 NEST Scientific USA Saliva-based Screening Revenue, Gross Margin and Market Share (2020-2022)

11.24.4 NEST Scientific USA Main Business Overview

11.24.5 NEST Scientific USA Latest Developments

11.25 Miraclean Technology Co. Ltd

11.25.1 Miraclean Technology Co. Ltd Company Information

11.25.2 Miraclean Technology Co. Ltd Saliva-based Screening Product Offered

11.25.3 Miraclean Technology Co. Ltd Saliva-based Screening Revenue, Gross Margin and Market Share (2020-2022)

11.25.4 Miraclean Technology Co. Ltd Main Business Overview

11.25.5 Miraclean Technology Co. Ltd Latest Developments

11.26 Mawi DNA Technologies

11.26.1 Mawi DNA Technologies Company Information

11.26.2 Mawi DNA Technologies Saliva-based Screening Product Offered

11.26.3 Mawi DNA Technologies Saliva-based Screening Revenue, Gross Margin and Market Share (2020-2022)

11.26.4 Mawi DNA Technologies Main Business Overview

11.26.5 Mawi DNA Technologies Latest Developments

11.27 Cell Projects Ltd.

11.27.1 Cell Projects Ltd. Company Information

11.27.2 Cell Projects Ltd. Saliva-based Screening Product Offered

11.27.3 Cell Projects Ltd. Saliva-based Screening Revenue, Gross Margin and Market Share (2020-2022)

11.27.4 Cell Projects Ltd. Main Business Overview

11.27.5 Cell Projects Ltd. Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Saliva-based Screening Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Direct Sample to PCR

Table 3. Major Players of RT-qPCR

Table 4. Major Players of Lateral Flow Assays

Table 5. Saliva-based Screening Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 6. Global Saliva-based Screening Market Size by Type (2017-2022) & ($ Millions)

Table 7. Global Saliva-based Screening Market Size Market Share by Type (2017-2022)

Table 8. Saliva-based Screening Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global Saliva-based Screening Market Size by Application (2017-2022) & ($ Millions)

Table 10. Global Saliva-based Screening Market Size Market Share by Application (2017-2022)

Table 11. Global Saliva-based Screening Revenue by Players (2020-2022) & ($ Millions)

Table 12. Global Saliva-based Screening Revenue Market Share by Player (2020-2022)

Table 13. Saliva-based Screening Key Players Head office and Products Offered

Table 14. Saliva-based Screening Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global Saliva-based Screening Market Size by Regions 2017-2022 & ($ Millions)

Table 18. Global Saliva-based Screening Market Size Market Share by Regions (2017-2022)

Table 19. Americas Saliva-based Screening Market Size by Country (2017-2022) & ($ Millions)

Table 20. Americas Saliva-based Screening Market Size Market Share by Country (2017-2022)

Table 21. Americas Saliva-based Screening Market Size by Type (2017-2022) & ($ Millions)

Table 22. Americas Saliva-based Screening Market Size Market Share by Type (2017-2022)

Table 23. Americas Saliva-based Screening Market Size by Application (2017-2022) & ($ Millions)

Table 24. Americas Saliva-based Screening Market Size Market Share by Application (2017-2022)

Table 25. APAC Saliva-based Screening Market Size by Region (2017-2022) & ($ Millions)

Table 26. APAC Saliva-based Screening Market Size Market Share by Region (2017-2022)

Table 27. APAC Saliva-based Screening Market Size by Type (2017-2022) & ($ Millions)

Table 28. APAC Saliva-based Screening Market Size Market Share by Type (2017-2022)

Table 29. APAC Saliva-based Screening Market Size by Application (2017-2022) & ($ Millions)

Table 30. APAC Saliva-based Screening Market Size Market Share by Application (2017-2022)

Table 31. Europe Saliva-based Screening Market Size by Country (2017-2022) & ($ Millions)

Table 32. Europe Saliva-based Screening Market Size Market Share by Country (2017-2022)

Table 33. Europe Saliva-based Screening Market Size by Type (2017-2022) & ($ Millions)

Table 34. Europe Saliva-based Screening Market Size Market Share by Type (2017-2022)

Table 35. Europe Saliva-based Screening Market Size by Application (2017-2022) & ($ Millions)

Table 36. Europe Saliva-based Screening Market Size Market Share by Application (2017-2022)

Table 37. Middle East & Africa Saliva-based Screening Market Size by Region (2017-2022) & ($ Millions)

Table 38. Middle East & Africa Saliva-based Screening Market Size Market Share by Region (2017-2022)

Table 39. Middle East & Africa Saliva-based Screening Market Size by Type (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Saliva-based Screening Market Size Market Share by Type (2017-2022)

Table 41. Middle East & Africa Saliva-based Screening Market Size by Application (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Saliva-based Screening Market Size Market Share by Application (2017-2022)

Table 43. Key Market Drivers & Growth Opportunities of Saliva-based Screening

Table 44. Key Market Challenges & Risks of Saliva-based Screening

Table 45. Key Industry Trends of Saliva-based Screening

Table 46. Global Saliva-based Screening Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 47. Global Saliva-based Screening Market Size Market Share Forecast by Regions (2023-2028)

Table 48. Global Saliva-based Screening Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 49. Global Saliva-based Screening Market Size Market Share Forecast by Type (2023-2028)

Table 50. Global Saliva-based Screening Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 51. Global Saliva-based Screening Market Size Market Share Forecast by Application (2023-2028)

Table 52. Thermo Fisher scientific Details, Company Type, Saliva-based Screening Area Served and Its Competitors

Table 53. Thermo Fisher scientific Saliva-based Screening Product Offered

Table 54. Thermo Fisher scientific Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 55. Thermo Fisher scientific Main Business

Table 56. Thermo Fisher scientific Latest Developments

Table 57. Qiagen Details, Company Type, Saliva-based Screening Area Served and Its Competitors

Table 58. Qiagen Saliva-based Screening Product Offered

Table 59. Qiagen Main Business

Table 60. Qiagen Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 61. Qiagen Latest Developments

Table 62. Hologic Details, Company Type, Saliva-based Screening Area Served and Its Competitors

Table 63. Hologic Saliva-based Screening Product Offered

Table 64. Hologic Main Business

Table 65. Hologic Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. Hologic Latest Developments

Table 67. Takara Bio Inc Details, Company Type, Saliva-based Screening Area Served and Its Competitors

Table 68. Takara Bio Inc Saliva-based Screening Product Offered

Table 69. Takara Bio Inc Main Business

Table 70. Takara Bio Inc Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. Takara Bio Inc Latest Developments

Table 72. Arcis Biotechnology Limited Details, Company Type, Saliva-based Screening Area Served and Its Competitors

Table 73. Arcis Biotechnology Limited Saliva-based Screening Product Offered

Table 74. Arcis Biotechnology Limited Main Business

Table 75. Arcis Biotechnology Limited Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. Arcis Biotechnology Limited Latest Developments

Table 77. GeneProof Details, Company Type, Saliva-based Screening Area Served and Its Competitors

Table 78. GeneProof Saliva-based Screening Product Offered

Table 79. GeneProof Main Business

Table 80. GeneProof Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. GeneProof Latest Developments

Table 82. Abacus ALS Details, Company Type, Saliva-based Screening Area Served and Its Competitors

Table 83. Abacus ALS Saliva-based Screening Product Offered

Table 84. Abacus ALS Main Business

Table 85. Abacus ALS Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. Abacus ALS Latest Developments

Table 87. Chai Inc. Details, Company Type, Saliva-based Screening Area Served and Its Competitors

Table 88. Chai Inc. Saliva-based Screening Product Offered

Table 89. Chai Inc. Main Business

Table 90. Chai Inc. Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. Chai Inc. Latest Developments

Table 92. Kolplast Group Details, Company Type, Saliva-based Screening Area Served and Its Competitors

Table 93. Kolplast Group Saliva-based Screening Product Offered

Table 94. Kolplast Group Main Business

Table 95. Kolplast Group Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. Kolplast Group Latest Developments

Table 97. Lucence Health INc Details, Company Type, Saliva-based Screening Area Served and Its Competitors

Table 98. Lucence Health INc Saliva-based Screening Product Offered

Table 99. Lucence Health INc Main Business

Table 100. Lucence Health INc Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 101. Lucence Health INc Latest Developments

Table 102. Vitagene Details, Company Type, Saliva-based Screening Area Served and Its Competitors

Table 103. Vitagene Saliva-based Screening Product Offered

Table 104. Vitagene Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 105. Vitagene Main Business

Table 106. Vitagene Latest Developments

Table 107. Therma Bright Inc Details, Company Type, Saliva-based Screening Area Served and Its Competitors

Table 108. Therma Bright Inc Saliva-based Screening Product Offered

Table 109. Therma Bright Inc Main Business

Table 110. Therma Bright Inc Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 111. Therma Bright Inc Latest Developments

Table 112. ACON Laboratories, Inc Details, Company Type, Saliva-based Screening Area Served and Its Competitors

Table 113. ACON Laboratories, Inc Saliva-based Screening Product Offered

Table 114. ACON Laboratories, Inc Main Business

Table 115. ACON Laboratories, Inc Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 116. ACON Laboratories, Inc Latest Developments

Table 117. TODA PHARMA Details, Company Type, Saliva-based Screening Area Served and Its Competitors

Table 118. TODA PHARMA Saliva-based Screening Product Offered

Table 119. TODA PHARMA Main Business

Table 120. TODA PHARMA Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 121. TODA PHARMA Latest Developments

Table 122. Norgen Biotek Corp. Details, Company Type, Saliva-based Screening Area Served and Its Competitors

Table 123. Norgen Biotek Corp. Saliva-based Screening Product Offered

Table 124. Norgen Biotek Corp. Main Business

Table 125. Norgen Biotek Corp. Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 126. Norgen Biotek Corp. Latest Developments

Table 127. Assure Tech. (Hangzhou) Co., Ltd Details, Company Type, Saliva-based Screening Area Served and Its Competitors

Table 128. Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Product Offered

Table 129. Assure Tech. (Hangzhou) Co., Ltd Main Business

Table 130. Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 131. Assure Tech. (Hangzhou) Co., Ltd Latest Developments

Table 132. Beijing Hotgen Biotech Co., Ltd Details, Company Type, Saliva-based Screening Area Served and Its Competitors

Table 133. Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Product Offered

Table 134. Beijing Hotgen Biotech Co., Ltd Main Business

Table 135. Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 136. Beijing Hotgen Biotech Co., Ltd Latest Developments

Table 137. Nantong Diagnos Biotechnology Co., Ltd Details, Company Type, Saliva-based Screening Area Served and Its Competitors

Table 138. Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Product Offered

Table 139. Nantong Diagnos Biotechnology Co., Ltd Main Business

Table 140. Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 141. Nantong Diagnos Biotechnology Co., Ltd Latest Developments

Table 142. NeuMoDx Molecular, Inc. Details, Company Type, Saliva-based Screening Area Served and Its Competitors

Table 143. NeuMoDx Molecular, Inc. Saliva-based Screening Product Offered

Table 144. NeuMoDx Molecular, Inc. Main Business

Table 145. NeuMoDx Molecular, Inc. Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 146. NeuMoDx Molecular, Inc. Latest Developments

Table 147. KYODO INTERNATIONAL INC. Details, Company Type, Saliva-based Screening Area Served and Its Competitors

Table 148. KYODO INTERNATIONAL INC. Saliva-based Screening Product Offered

Table 149. KYODO INTERNATIONAL INC. Main Business

Table 150. KYODO INTERNATIONAL INC. Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 151. KYODO INTERNATIONAL INC. Latest Developments

Table 152. Canvax Details, Company Type, Saliva-based Screening Area Served and Its Competitors

Table 153. Canvax Saliva-based Screening Product Offered

Table 154. Canvax Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 155. Canvax Main Business

Table 156. Canvax Latest Developments

Table 157. Zymo Research Corporation. Details, Company Type, Saliva-based Screening Area Served and Its Competitors

Table 158. Zymo Research Corporation. Saliva-based Screening Product Offered

Table 159. Zymo Research Corporation. Main Business

Table 160. Zymo Research Corporation. Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 161. Zymo Research Corporation. Latest Developments

Table 162. Salimetrics Details, Company Type, Saliva-based Screening Area Served and Its Competitors

Table 163. Salimetrics Saliva-based Screening Product Offered

Table 164. Salimetrics Main Business

Table 165. Salimetrics Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 166. Salimetrics Latest Developments

Table 167. NEST Scientific USA Details, Company Type, Saliva-based Screening Area Served and Its Competitors

Table 168. NEST Scientific USA Saliva-based Screening Product Offered

Table 169. NEST Scientific USA Main Business

Table 170. NEST Scientific USA Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 171. NEST Scientific USA Latest Developments

Table 172. Miraclean Technology Co. Ltd Details, Company Type, Saliva-based Screening Area Served and Its Competitors

Table 173. Miraclean Technology Co. Ltd Saliva-based Screening Product Offered

Table 174. Miraclean Technology Co. Ltd Main Business

Table 175. Miraclean Technology Co. Ltd Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 176. Miraclean Technology Co. Ltd Latest Developments

Table 177. Mawi DNA Technologies Details, Company Type, Saliva-based Screening Area Served and Its Competitors

Table 178. Mawi DNA Technologies Saliva-based Screening Product Offered

Table 179. Mawi DNA Technologies Main Business

Table 180. Mawi DNA Technologies Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 181. Mawi DNA Technologies Latest Developments

Table 182. Cell Projects Ltd. Details, Company Type, Saliva-based Screening Area Served and Its Competitors

Table 183. Cell Projects Ltd. Saliva-based Screening Product Offered

Table 184. Cell Projects Ltd. Main Business

Table 185. Cell Projects Ltd. Saliva-based Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 186. Cell Projects Ltd. Latest Developments

List of Figures

Figure 1. Saliva-based Screening Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Saliva-based Screening Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Saliva-based Screening Market Size Market Share by Type in 2021

Figure 7. Saliva-based Screening in Diagnostic Laboratories

Figure 8. Global Saliva-based Screening Market: Diagnostic Laboratories (2017-2022) & ($ Millions)

Figure 9. Saliva-based Screening in Hospitals & Clinics

Figure 10. Global Saliva-based Screening Market: Hospitals & Clinics (2017-2022) & ($ Millions)

Figure 11. Saliva-based Screening in Others

Figure 12. Global Saliva-based Screening Market: Others (2017-2022) & ($ Millions)

Figure 13. Global Saliva-based Screening Market Size Market Share by Application in 2021

Figure 14. Global Saliva-based Screening Revenue Market Share by Player in 2021

Figure 15. Global Saliva-based Screening Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Saliva-based Screening Market Size 2017-2022 ($ Millions)

Figure 17. APAC Saliva-based Screening Market Size 2017-2022 ($ Millions)

Figure 18. Europe Saliva-based Screening Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Saliva-based Screening Market Size 2017-2022 ($ Millions)

Figure 20. Americas Saliva-based Screening Value Market Share by Country in 2021

Figure 21. Americas Saliva-based Screening Consumption Market Share by Type in 2021

Figure 22. Americas Saliva-based Screening Market Size Market Share by Application in 2021

Figure 23. United States Saliva-based Screening Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Saliva-based Screening Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Saliva-based Screening Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Saliva-based Screening Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Saliva-based Screening Market Size Market Share by Region in 2021

Figure 28. APAC Saliva-based Screening Market Size Market Share by Application in 2021

Figure 29. China Saliva-based Screening Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Saliva-based Screening Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Saliva-based Screening Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Saliva-based Screening Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Saliva-based Screening Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Saliva-based Screening Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Saliva-based Screening Market Size Market Share by Country in 2021

Figure 36. Europe Saliva-based Screening Market Size Market Share by Type in 2021

Figure 37. Europe Saliva-based Screening Market Size Market Share by Application in 2021

Figure 38. Germany Saliva-based Screening Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Saliva-based Screening Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Saliva-based Screening Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Saliva-based Screening Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Saliva-based Screening Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Saliva-based Screening Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Saliva-based Screening Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Saliva-based Screening Market Size Market Share by Application in 2021

Figure 46. Egypt Saliva-based Screening Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Saliva-based Screening Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Saliva-based Screening Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Saliva-based Screening Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Saliva-based Screening Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Saliva-based Screening Market Size 2023-2028 ($ Millions)

Figure 52. APAC Saliva-based Screening Market Size 2023-2028 ($ Millions)

Figure 53. Europe Saliva-based Screening Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Saliva-based Screening Market Size 2023-2028 ($ Millions)

Figure 55. United States Saliva-based Screening Market Size 2023-2028 ($ Millions)

Figure 56. Canada Saliva-based Screening Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Saliva-based Screening Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Saliva-based Screening Market Size 2023-2028 ($ Millions)

Figure 59. China Saliva-based Screening Market Size 2023-2028 ($ Millions)

Figure 60. Japan Saliva-based Screening Market Size 2023-2028 ($ Millions)

Figure 61. Korea Saliva-based Screening Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Saliva-based Screening Market Size 2023-2028 ($ Millions)

Figure 63. India Saliva-based Screening Market Size 2023-2028 ($ Millions)

Figure 64. Australia Saliva-based Screening Market Size 2023-2028 ($ Millions)

Figure 65. Germany Saliva-based Screening Market Size 2023-2028 ($ Millions)

Figure 66. France Saliva-based Screening Market Size 2023-2028 ($ Millions)

Figure 67. UK Saliva-based Screening Market Size 2023-2028 ($ Millions)

Figure 68. Italy Saliva-based Screening Market Size 2023-2028 ($ Millions)

Figure 69. Russia Saliva-based Screening Market Size 2023-2028 ($ Millions)

Figure 70. Spain Saliva-based Screening Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Saliva-based Screening Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Saliva-based Screening Market Size 2023-2028 ($ Millions)

Figure 73. Israel Saliva-based Screening Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Saliva-based Screening Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Saliva-based Screening Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450